$AEHR

AEHR (AEHR) files Form 144 for 2,000-share planned common stock sale

AEHR filed a Form 144 stating it plans to sell 2,000 shares of its common stock through Fidelity Brokerage Services LLC. The filing cites an aggregate value of $273,000 and a sale date on or after 08/14/2026 on NASDAQ. It also references restricted stock vesting tranches of 47, 248, 795, 478, and 432 shares in 2024-2025.

Original reporting
Published Aug 14, 2026, 3:01 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 14, 2026, 3:27 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$AEHR
Neutral
medium confidence
Mentioned
$AEHR
Relevance
4/10
alphai data visualization · based on stocktitan.net
Decision brief

The 30-second read

$AEHRNeutralLow
01

Why it matters

This disclosure provides a concrete timeline and share count for a planned sale, which can influence short-term sentiment but does not change AEHR’s fundamentals by itself.

02

Market read

Traders may monitor for any follow-through selling around the stated 08/14/2026 window, but the disclosed magnitude suggests limited market impact.

03

What to watch

Actual selling may be delayed, executed in smaller tranches, or not occur; liquidity and float size can dwarf a $273k planned sale.

Relevance 4/10Novelty 4/10Timing: on or after 08/14/2026 planned sale window

Background

Form 144 is an SEC notice used when insiders or affiliates plan to sell restricted or controlled shares.

Company-level read

Ticker impact

$AEHRNeutralMedium confidence
Context

AEHR filed Form 144 to sell 2,000 shares on or after 08/14/2026, signaling planned insider/comp-related supply into the market.

Expected impact

Likely limited, with any impact more sentiment-driven than fundamental.

Evidence & confidence

The filing discloses a specific planned sale size ($273k) and timing (on or after 08/14/2026) but no new operating or financial catalyst.

Market effects

No clear sector read-through; this is company-specific planned selling disclosure.

None indicated beyond AEHR’s own NASDAQ trading.

None indicated.

Counterpoint

The Form 144 is only an intention to sell, and the small share count may not meaningfully affect price.

Key entities

  • AEHR

    NASDAQ-listed company that filed Form 144 for a planned sale of 2,000 shares.

  • Fidelity Brokerage Services LLC

    Broker named in the Form 144 as the sales agent for the planned disposition.

Related articles

$AEHRHighAI 8/10

AEHR Stock Rips On AI Orders And Bullish Jefferies Call

Aehr Test Systems (NASDAQ: AEHR) rose about 7% after upbeat earnings and strong semiconductor test demand. The article cites a $22M AI follow-on production order and a Jefferies Buy call with a $175 price target. It also notes quarterly revenue of about $18.84M, gross margin 35.3%, and $116.36M cash.

$AEHRMed

Aehr Test Systems Soars Again Friday. Shares Now Up More than 500% On the Year.

Jefferies initiated coverage of Aehr Test Systems (AEHR) with a Buy rating and $175 price target, citing a conservative model based on existing production and backlog. The stock rose about 8% midday and is up over 510% YTD, after AI-driven semiconductor testing demand. Peers TER, COHU, FORM, and ONTO also gained; AEHR faces valuation and revenue volatility risks.

$AEHRHighAI 9/10

Why is Aehr Test Systems stock surging today?

Investing.com reports Aehr Test Systems (AEHR) shares rose 10.7% after the company said it received a $22 million follow-on production order from a lead wafer-level AI processor customer. The order covers FOX-XP burn-in systems, FOX WaferPak contactors, and Auto Aligners. AEHR also reported fiscal Q4 2026 profit of $0.11 EPS on ~$18.8M revenue and guided fiscal 2027 revenue to $130–$150M.

$AEHRMedAI 8/10

A $22 Million Reason Why AEHR Stock Is Up Today

Aehr Test Systems (AEHR) shares rose Aug. 12 after the company said it received a $22 million follow-on production order from its lead AI processor customer for automated wafer-level test systems. The order covers FOX-XP WLBI systems and related components, shipping over six months for installation in Taiwan. Investors cited demand tied to AI chip manufacturing; AEHR trades around 212x forward earnings and has a mean $115 price target.